Dante Labs highlights advancements to its drug discovery development program, demonstrating the value of genomic data to drug discovery

- Company announces rebranding to Dante Genomics to reflect its broader global efforts -NEW YORK, May 26, 2022, a global leader in genomics and precision medicine, highlights significant progress made

Related Keywords

Italy ,Italian ,Andrea Riposati ,Kostenloser Wertpapierhandel ,Laura Dangelo ,Mattia Capulli , ,Dante Genomics ,Chief Scientific Officer ,Dante ,Labs ,Highlights ,Advancements ,Drug ,Discovery ,Development ,Program ,Emonstrating ,Value ,Enomic ,Data ,